Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Novozymes AS DRC (NVZMY)
Novozymes AS DRC stock price live, this page displays OTC NVZMY stock exchange data. View the NVZMY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Novozymes AS DRC real time stock price chart below.
What Is the Novozymes AS DRC Stock Price Today?
The Novozymes AS DRC stock price today is 69.39.
What Is the Stock Symbol for Novozymes AS DRC?
The stock symbol for Novozymes AS DRC is ""NVZMY.""
What Stock Exchange Does Novozymes AS DRC Trade On?
Novozymes AS DRC is listed and trades on the OTC Markets stock exchange.
Is Novozymes AS DRC a Good Stock to Buy?
Determining whether Novozymes AS DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NVZMY quote. (ISIN: US6701081092)
What Is the Novozymes AS DRC Stock Price Today?
The Novozymes AS DRC stock price today is 69.39.
What Is the Stock Symbol for Novozymes AS DRC?
The stock symbol for Novozymes AS DRC is ""NVZMY.""
What Stock Exchange Does Novozymes AS DRC Trade On?
Novozymes AS DRC is listed and trades on the OTC Markets stock exchange.
Is Novozymes AS DRC a Good Stock to Buy?
Determining whether Novozymes AS DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NVZMY quote. (ISIN: US6701081092)
69.39
-0.46(-0.66%)
Closed·
Fair Value
An estimate of a Novozymes AS DRC's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
68.29
69.47
52 wk Range
53.95
75.99
NVZMY Scorecard
Full Analysis
Net income is expected to grow this year
Unusual trading volume
Fair Value
An estimate of a Novozymes AS DRC's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
68.2969.47
52 wk Range
53.9575.99
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.05%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.05%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NVZMY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Novozymes AS DRC's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
82.50
Upside
+18.89%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Novozymes AS DRC Company Profile
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, and microbial and medical cleaning services. Further, it offers corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; and fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, wastewater, sewage, and renewable diesel solutions; and agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, enzyme, and biogas solutions. It also provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
Compare NVZMY to Peers and Sector
Metrics to compare | NVZMY | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipNVZMYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 59.5x | 18.4x | 2.7x | |
PEG Ratio | 1.22 | 0.06 | 0.00 | |
Price/Book | 2.4x | 1.4x | 1.6x | |
Price / LTM Sales | 6.7x | 0.9x | 1.3x | |
Upside (Analyst Target) | 18.1% | 16.5% | 18.5% | |
Fair Value Upside | Unlock | 7.0% | 0.9% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 82.50
(+18.89% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
0.4737 / 0.41
Revenue / Forecast
1.22B / 1.13B
People Also Watch
FAQ
What Stock Exchange Does Novozymes AS DRC Trade On?
Novozymes AS DRC is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Novozymes AS DRC?
The stock symbol for Novozymes AS DRC is "NVZMY."
What Is the Novozymes AS DRC Market Cap?
As of today, Novozymes AS DRC market cap is 32.05B.
What Is Novozymes AS DRC's Earnings Per Share (TTM)?
The Novozymes AS DRC EPS (TTM) is 1.58.
When Is the Next Novozymes AS DRC Earnings Date?
Novozymes AS DRC will release its next earnings report on 20 Aug 2025.
From a Technical Analysis Perspective, Is NVZMY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Novozymes AS DRC Stock Split?
Novozymes AS DRC has split 1 times.
How Many Employees Does Novozymes AS DRC Have?
Novozymes AS DRC has 10582 employees.
What is the current trading status of Novozymes AS DRC (NVZMY)?
As of 22 Jul 2025, Novozymes AS DRC (NVZMY) is trading at a price of 69.39, with a previous close of 69.85. The stock has fluctuated within a day range of 68.29 to 69.47, while its 52-week range spans from 53.95 to 75.99.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.